INS and Parkinson disease: Chronic insulin signalling, hyperinsulinaemia, is mechanistically associated with increased incidence of chronic diseases of ageing, including the following: CVD, cancer, cognitive decline and dementias such as Alzheimer’s and Parkinson’s diseases, and T2DM [30].